As the Trump administration looks to unravel the Afforadable Care Act, Boulder County’s medical device industry is hopeful that a tax on its products, designed to help fund the law, will be repealed — and soon.
A two-year moratorium designed to give them some relief from the measure is set to expire at the end of this year, but they say true balance won’t be restored until the tax is completely dead.
In the meantime, a local industry known for its flexibility and innovation has seen a 77 percent decline in venture capital as investors look to larger, more established companies.
“Any tax has an impact, but most of the bigger companies can absorb it,” said Robert Kline, newly appointed CEO of Boulder’s EndoShape.
“But when you’re a small, emerging company, you’re talking about the very survival of the company.”
The tax in question is a 2.3 percent tax on the sale price of the medical device. It was passed as part of the Health Care and Education Reconciliation Act of 2010, a modification to the ACA, and went into effect in 2013.
Read the entire story at dailycamera.com.
